Overview
The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.
Description
In this placebo-controlled study, blood is taken on the first day of the study, followed by a 90-day intervention with xanthohumol or a placebo, which is taken twice daily. Blood samples will be taken on day 0, day 45 and day 90. Should the study participants develop a respiratory infection during the study, they will be asked to perform a self-test.
Eligibility
Inclusion Criteria:
- healthy
- BMI >18 kg/m² or < 28kg/m²
Exclusion Criteria:
- food intolerances
- food allergies
- chronic inflammatory diseases
- metabolic diseases
- viral or bacterial infections within the last 3 weeks of inclusion
- intake of immunosuppressive medication
- severe acute respiratory syndrome coronavirus type 2-infection in the last 4 months
- influenza infection in the "current" flu season